Evaluate Efficacy of Devimistat in Combination With mFFX in 2nd Line Patients With Metastatic Pancreatic Cancer
Clinical trial NCT06518538 · WITHDRAWN
Trial details
- NCT number
- NCT06518538
- Sponsor
- Cornerstone Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-15
- Primary completion
- 2026-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.